ORCHID PHARMA
|
ORCHID PHARMA Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹15 Cr | ₹15 Cr | ₹51 Cr | ₹41 Cr | ₹41 Cr |
| Equity - Authorised | ₹165 Cr | ₹165 Cr | ₹150 Cr | ₹150 Cr | ₹150 Cr |
| Equity - Issued | ₹15 Cr | ₹15 Cr | ₹51 Cr | ₹41 Cr | ₹41 Cr |
| Equity Paid Up | ₹15 Cr | ₹15 Cr | ₹51 Cr | ₹41 Cr | ₹41 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹45 Cr | ₹45 Cr | - | - | - |
| Total Reserves | ₹1,504 Cr | ₹1,494 Cr | ₹1,119 Cr | ₹648 Cr | ₹607 Cr |
| Securities Premium | ₹898 Cr | ₹898 Cr | ₹847 Cr | ₹464 Cr | ₹464 Cr |
| Capital Reserves | ₹1,629 Cr | ₹1,629 Cr | ₹1,682 Cr | ₹1,682 Cr | ₹1,682 Cr |
| Profit & Loss Account Balance | ₹-1,792 Cr | ₹-1,803 Cr | ₹-2,177 Cr | ₹-2,268 Cr | ₹-2,314 Cr |
| General Reserves | ₹631 Cr | ₹631 Cr | ₹559 Cr | ₹559 Cr | ₹559 Cr |
| Other Reserves | ₹139 Cr | ₹140 Cr | ₹208 Cr | ₹211 Cr | ₹216 Cr |
| Reserve excluding Revaluation Reserve | ₹1,504 Cr | ₹1,494 Cr | ₹1,119 Cr | ₹648 Cr | ₹607 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹1,564 Cr | ₹1,554 Cr | ₹1,169 Cr | ₹689 Cr | ₹647 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹185 Cr | ₹0.03 Cr | ₹0.22 Cr | ₹40 Cr | ₹111 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹214 Cr | ₹0.30 Cr | ₹0.22 Cr | ₹82 Cr | ₹148 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | ₹-29 Cr | ₹-0.27 Cr | - | ₹-42 Cr | ₹-37 Cr |
| Unsecured Loans | - | ₹10.00 Cr | ₹120 Cr | ₹109 Cr | ₹97 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | ₹10.00 Cr | - | - | - |
| Other Unsecured Loan | - | - | ₹120 Cr | ₹109 Cr | ₹97 Cr |
| Deferred Tax Assets / Liabilities | ₹-0.29 Cr | ₹-0.10 Cr | - | ₹3.23 Cr | ₹3.23 Cr |
| Deferred Tax Assets | ₹120 Cr | ₹123 Cr | ₹111 Cr | ₹86 Cr | ₹83 Cr |
| Deferred Tax Liability | ₹119 Cr | ₹122 Cr | ₹111 Cr | ₹89 Cr | ₹86 Cr |
| Other Long Term Liabilities | ₹4.73 Cr | ₹0.04 Cr | ₹0.37 Cr | - | - |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹13 Cr | ₹4.70 Cr | ₹3.63 Cr | ₹13 Cr | ₹11 Cr |
| Total Non-Current Liabilities | ₹203 Cr | ₹15 Cr | ₹124 Cr | ₹165 Cr | ₹222 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹347 Cr | ₹336 Cr | ₹230 Cr | ₹174 Cr | ₹168 Cr |
| Sundry Creditors | ₹347 Cr | ₹336 Cr | ₹230 Cr | ₹174 Cr | ₹168 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹56 Cr | ₹27 Cr | ₹14 Cr | ₹53 Cr | ₹47 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹6.63 Cr | ₹5.85 Cr | ₹1.95 Cr | ₹1.68 Cr | ₹8.79 Cr |
| Interest Accrued But Not Due | ₹1.34 Cr | ₹2.45 Cr | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹48 Cr | ₹18 Cr | ₹12 Cr | ₹51 Cr | ₹38 Cr |
| Short Term Borrowings | ₹88 Cr | ₹143 Cr | ₹14 Cr | ₹141 Cr | ₹23 Cr |
| Secured ST Loans repayable on Demands | ₹66 Cr | ₹70 Cr | ₹14 Cr | ₹141 Cr | ₹23 Cr |
| Working Capital Loans- Sec | ₹66 Cr | ₹70 Cr | ₹14 Cr | ₹141 Cr | ₹23 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-45 Cr | ₹2.63 Cr | ₹-14 Cr | ₹-141 Cr | ₹-23 Cr |
| Short Term Provisions | ₹0.80 Cr | ₹2.86 Cr | ₹2.09 Cr | ₹3.49 Cr | ₹3.01 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | - | - | - | - | - |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹0.80 Cr | ₹2.86 Cr | ₹2.09 Cr | ₹3.49 Cr | ₹3.01 Cr |
| Total Current Liabilities | ₹491 Cr | ₹509 Cr | ₹260 Cr | ₹372 Cr | ₹241 Cr |
| Total Liabilities | ₹2,258 Cr | ₹2,077 Cr | ₹1,554 Cr | ₹1,225 Cr | ₹1,111 Cr |
| ASSETS | |||||
| Gross Block | ₹1,517 Cr | ₹1,499 Cr | ₹1,301 Cr | ₹1,221 Cr | ₹1,176 Cr |
| Less: Accumulated Depreciation | ₹825 Cr | ₹791 Cr | ₹681 Cr | ₹647 Cr | ₹593 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹692 Cr | ₹708 Cr | ₹620 Cr | ₹573 Cr | ₹584 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹341 Cr | ₹64 Cr | ₹16 Cr | ₹46 Cr | ₹9.78 Cr |
| Non Current Investments | ₹67 Cr | ₹60 Cr | ₹46 Cr | ₹44 Cr | ₹45 Cr |
| Long Term Investment | ₹67 Cr | ₹60 Cr | ₹46 Cr | ₹44 Cr | ₹45 Cr |
| Quoted | ₹0.26 Cr | ₹0.20 Cr | ₹0.25 Cr | ₹0.14 Cr | ₹0.09 Cr |
| Unquoted | ₹83 Cr | ₹70 Cr | ₹46 Cr | ₹45 Cr | ₹46 Cr |
| Long Term Loans & Advances | ₹156 Cr | ₹131 Cr | ₹66 Cr | ₹60 Cr | ₹74 Cr |
| Other Non Current Assets | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | - | ₹0.01 Cr |
| Total Non-Current Assets | ₹1,329 Cr | ₹980 Cr | ₹763 Cr | ₹724 Cr | ₹713 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹372 Cr | ₹457 Cr | ₹264 Cr | ₹229 Cr | ₹173 Cr |
| Raw Materials | ₹133 Cr | ₹149 Cr | ₹66 Cr | ₹76 Cr | ₹43 Cr |
| Work-in Progress | ₹136 Cr | ₹193 Cr | ₹115 Cr | ₹77 Cr | ₹69 Cr |
| Finished Goods | ₹84 Cr | ₹105 Cr | ₹74 Cr | ₹68 Cr | ₹55 Cr |
| Packing Materials | ₹3.57 Cr | ₹2.94 Cr | ₹2.90 Cr | ₹3.99 Cr | ₹2.36 Cr |
| Stores  and Spare | ₹9.52 Cr | ₹6.32 Cr | ₹6.03 Cr | ₹3.46 Cr | ₹3.54 Cr |
| Other Inventory | ₹5.92 Cr | ₹1.78 Cr | - | - | - |
| Sundry Debtors | ₹381 Cr | ₹353 Cr | ₹196 Cr | ₹215 Cr | ₹171 Cr |
| Debtors more than Six months | ₹74 Cr | ₹76 Cr | ₹50 Cr | ₹47 Cr | ₹13 Cr |
| Debtors Others | ₹353 Cr | ₹352 Cr | ₹189 Cr | ₹212 Cr | ₹200 Cr |
| Cash and Bank | ₹84 Cr | ₹201 Cr | ₹267 Cr | ₹31 Cr | ₹8.06 Cr |
| Cash in hand | ₹0.10 Cr | ₹0.14 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.04 Cr |
| Balances at Bank | ₹83 Cr | ₹200 Cr | ₹267 Cr | ₹31 Cr | ₹8.03 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹17 Cr | ₹11 Cr | ₹7.05 Cr | ₹3.95 Cr | ₹13 Cr |
| Interest accrued on Investments | ₹0.87 Cr | ₹4.11 Cr | ₹4.51 Cr | ₹0.16 Cr | ₹0.00 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹11 Cr | ₹2.57 Cr | ₹2.22 Cr | ₹3.79 Cr | ₹7.12 Cr |
| Other current_assets | ₹5.40 Cr | ₹4.19 Cr | ₹0.33 Cr | - | ₹5.89 Cr |
| Short Term Loans and Advances | ₹75 Cr | ₹76 Cr | ₹57 Cr | ₹23 Cr | ₹20 Cr |
| Advances recoverable in cash or in kind | ₹14 Cr | ₹10 Cr | ₹11 Cr | ₹9.64 Cr | ₹3.47 Cr |
| Advance income tax and TDS | - | - | ₹1.64 Cr | ₹0.95 Cr | ₹0.32 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹61 Cr | ₹65 Cr | ₹45 Cr | ₹12 Cr | ₹16 Cr |
| Total Current Assets | ₹929 Cr | ₹1,097 Cr | ₹791 Cr | ₹501 Cr | ₹384 Cr |
| Net Current Assets (Including Current Investments) | ₹438 Cr | ₹589 Cr | ₹531 Cr | ₹129 Cr | ₹144 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹2,258 Cr | ₹2,077 Cr | ₹1,554 Cr | ₹1,225 Cr | ₹1,111 Cr |
| Contingent Liabilities | ₹25 Cr | ₹18 Cr | ₹57 Cr | ₹42 Cr | ₹43 Cr |
| Total Debt | ₹301 Cr | ₹153 Cr | ₹134 Cr | ₹331 Cr | ₹268 Cr |
| Book Value | - | 249.86 | 230.58 | 168.72 | 158.61 |
| Adjusted Book Value | 993.34 | 986.56 | 230.58 | 168.72 | 158.61 |
Compare Balance Sheet of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹6,378.5 Cr | -1.5% | 9.6% | 39.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -1.5% |
9.6% |
39.1% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses